Catarina Abreu

Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Metastatic Colorectal Cancer

Papillary Thyroid

Top Venues

Exploration of targeted anti-tumor therapy

British journal of clinical pharmacology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Vanessa Patel, Sandra Casimiro, Catarina Abreu, Tiago Barroso, Rita Teixeira de Sousa, Sofia Torres, Leonor Abreu Ribeiro, Gonçalo Nogueira-Costa, Helena Luna Pais, Conceição Pinto, Leila Costa, Luís Costa
DNA damage targeted therapy for advanced breast cancer. Exploration of targeted anti-tumor therapy 5 (3) (2024)
Vanessa Patel, Sandra Casimiro, Catarina Abreu, Tiago Barroso, Rita Teixeira de Sousa, Sofia Torres, Leonor Abreu Ribeiro, Gonçalo Nogueira-Costa, Helena Luna Pais, Conceição Pinto, Leila Costa, Luís Costa
DNA damage targeted therapy for advanced breast cancer. Exploration of targeted anti-tumor therapy 5 (3) (2024)
Inês Soares de Pinho, Catarina Abreu, Inês Gomes, Sandra Casimiro, Teresa Raquel Pacheco, Rita Teixeira de Sousa, Luis Costa
Exploring new pathways in endocrine-resistant breast cancer. Exploration of targeted anti-tumor therapy 3 (3) (2022)
Raquel Cruz-Duarte, Cátia Rebelo de Almeida, Magda Negrão, Afonso Fernandes, Paula Borralho, Daniel Sobral, Lina M Gallego-Paez, Daniel Machado, João Gramaça, José Vílchez, Ana T Xavier, Miguel Godinho Ferreira, Ana R Miranda, Helder Mansinho, Maria J Brito, Teresa R Pacheco, Catarina Abreu, Ana Lucia-Costa, André Mansinho, Rita Fior, Luis Costa, Marta Martins
Predictive and Therapeutic Implications of a Novel PLCγ1/SHP2-Driven Mechanism of Cetuximab Resistance in Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (6) (2022)
Maria Rita Dionísio, André Mansinho, Catarina Abreu, Filipa Ferreira da Silva, Sandra Casimiro, Luis Costa
Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer-induced bone loss. British journal of clinical pharmacology 85 (6) (2019)